Market Closed -
Bombay S.E.
03:30:51 15/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
44.01
INR
|
+3.07%
|
|
+2.59%
|
+11.76%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
359.9
|
325.1
|
103.7
|
203.2
|
265.4
|
239.9
|
Enterprise Value (EV)
1 |
652.7
|
447.4
|
131.4
|
373
|
339.4
|
239.9
|
P/E ratio
|
15.8
x
|
8.82
x
|
8.27
x
|
14.9
x
|
8.43
x
|
-1,690
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.28
x
|
0.22
x
|
0.08
x
|
0.14
x
|
0.15
x
|
0.16
x
|
EV / Revenue
|
0.51
x
|
0.3
x
|
0.1
x
|
0.25
x
|
0.19
x
|
0.16
x
|
EV / EBITDA
|
10.7
x
|
6.19
x
|
3.86
x
|
12.4
x
|
13.7
x
|
27.9
x
|
EV / FCF
|
-6.6
x
|
2.68
x
|
1.34
x
|
-2.48
x
|
-82
x
|
-
|
FCF Yield
|
-15.2%
|
37.3%
|
74.5%
|
-40.2%
|
-1.22%
|
-
|
Price to Book
|
1.31
x
|
1.04
x
|
0.32
x
|
0.6
x
|
0.71
x
|
-
|
Nbr of stocks (in thousands)
|
10,209
|
10,209
|
10,209
|
10,209
|
10,209
|
10,209
|
Reference price
2 |
35.25
|
31.85
|
10.16
|
19.90
|
26.00
|
23.50
|
Announcement Date
|
28/09/18
|
26/08/19
|
04/09/20
|
02/08/21
|
05/08/22
|
20/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,289
|
1,472
|
1,319
|
1,502
|
1,792
|
1,468
|
EBITDA
1 |
60.82
|
72.33
|
34.06
|
30
|
24.84
|
8.608
|
EBIT
1 |
52.79
|
63.07
|
24.68
|
20.67
|
16.1
|
-0.128
|
Operating Margin
|
4.1%
|
4.28%
|
1.87%
|
1.38%
|
0.9%
|
-0.01%
|
Earnings before Tax (EBT)
1 |
33.63
|
46.39
|
16.45
|
17.91
|
40.69
|
-0.696
|
Net income
1 |
22.77
|
36.89
|
12.54
|
13.59
|
31.47
|
-0.142
|
Net margin
|
1.77%
|
2.51%
|
0.95%
|
0.91%
|
1.76%
|
-0.01%
|
EPS
2 |
2.231
|
3.613
|
1.228
|
1.332
|
3.083
|
-0.0139
|
Free Cash Flow
1 |
-98.97
|
166.8
|
97.83
|
-150.1
|
-4.138
|
-
|
FCF margin
|
-7.68%
|
11.33%
|
7.42%
|
-10%
|
-0.23%
|
-
|
FCF Conversion (EBITDA)
|
-
|
230.64%
|
287.22%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
452.29%
|
780.45%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/09/18
|
26/08/19
|
04/09/20
|
02/08/21
|
05/08/22
|
20/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
293
|
122
|
27.6
|
170
|
74
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.816
x
|
1.69
x
|
0.8117
x
|
5.662
x
|
2.98
x
|
-
|
Free Cash Flow
1 |
-99
|
167
|
97.8
|
-150
|
-4.14
|
-
|
ROE (net income / shareholders' equity)
|
8.68%
|
12.6%
|
3.93%
|
4.09%
|
8.64%
|
-
|
ROA (Net income/ Total Assets)
|
5.17%
|
6.02%
|
2.64%
|
1.9%
|
1.38%
|
-
|
Assets
1 |
440.6
|
613.2
|
475.7
|
715.3
|
2,279
|
-
|
Book Value Per Share
2 |
26.80
|
30.60
|
31.90
|
33.20
|
36.40
|
-
|
Cash Flow per Share
2 |
0.9000
|
1.520
|
0.4200
|
0.3800
|
1.230
|
-
|
Capex
1 |
23.5
|
9.92
|
2.21
|
2.04
|
11.3
|
-
|
Capex / Sales
|
1.82%
|
0.67%
|
0.17%
|
0.14%
|
0.63%
|
-
|
Announcement Date
|
28/09/18
|
26/08/19
|
04/09/20
|
02/08/21
|
05/08/22
|
20/07/23
|
|
1st Jan change
|
Capi.
|
---|
| +11.76% | 5.22M | | +16.91% | 66.22B | | +3.25% | 49.24B | | +16.73% | 41.4B | | +21.48% | 26.62B | | +13.36% | 19.84B | | +2.79% | 17.44B | | -6.24% | 15.92B | | -23.54% | 15.57B | | +2.27% | 15.45B |
Other Specialty Chemicals
|